What a lot of posters here fail to realise is ANP have the backing of the grand father of Australian Biotechs in Leon. It would be interesting to have an audience with Leon and hear what he thinks about all things ANP. The science, the board, the business and its future.
Ann: ATL1102 Revised Plans accelerate reporting of unblinded data, page-189
-
- There are more pages in this discussion • 163 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.010(10.0%) |
Mkt cap ! $99.16M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.5¢ | 10.5¢ | $160.3K | 1.467M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 577880 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 114554 | 3 |
View Market Depth
| Last trade - 11.46am 30/09/2024 (20 minute delay) ? |
| PER (ASX) Chart |